Insider Trading activities at Nuvalent, Inc. (NUVL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvalent, Inc. (NUVL) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvalent, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1861560.

Total stock buying since 2021: $34,270,000.
Total stock sales since 2021: $506,562,628.
Total stock option exercises since 2021: $20,817,339.


 1   2 
11 insiders reported insider trading activities at Nuvalent, Inc. (NUVL):
Insider trading activities of Noci Darlene
Insider trading activities of Balcom Alexandra
Insider trading activities of Miller Deborah Ann
Insider trading activities of Protopapas Anna
Insider trading activities of Turner Christopher Durant
Insider trading activities of Pelish Henry E.
Insider trading activities of Conley Emily
Insider trading activities of Hack Andrew A. F.
Insider trading activities of Porter James Richard
Insider trading activities of Deerfield Private Design Fund Iv, L.p.
Insider trading activities of Shair Matthew

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Nuvalent, Inc. (NUVL).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 681,254 $54,090,684 648,440 $13,047,258
2024 0 $0 4,713,129 $416,846,343 305,448 $5,726,848
2023 0 $0 481,138 $29,610,739 261,138 $1,884,101
2022 650,000 $21,775,000 227,400 $6,014,862 58,513 $159,132
2021 735,000 $12,495,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Nuvalent, Inc. (NUVL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 116,313 $9,394,672 116,313 $1,929,314
2025-08 0 $0 36,500 $2,763,925 41,507 $766,926
2025-07 0 $0 246,645 $20,644,796 244,500 $4,699,485
2025-06 0 $0 62,000 $4,881,966 62,000 $1,556,439
2025-05 0 $0 31,000 $2,176,191 31,000 $836,450
2025-04 0 $0 31,000 $2,175,685 31,000 $809,550
2025-03 0 $0 65,000 $4,787,330 65,000 $942,480
2025-02 0 $0 29,000 $2,282,329 27,000 $751,950
2025-01 0 $0 63,796 $4,983,790 30,120 $754,664
2024-12 0 $0 1,277,000 $112,341,170 73,114 $828,758
2024-11 0 $0 44,000 $3,986,275 42,000 $1,102,450
2024-10 0 $0 2,039,000 $199,352,285 37,000 $1,030,450
2024-09 0 $0 60,795 $5,903,019 26,000 $545,260
2024-08 0 $0 39,834 $3,333,628 27,334 $602,435
2024-07 0 $0 21,000 $1,643,760 19,000 $351,370
2024-06 0 $0 25,000 $1,935,303 23,000 $450,730
2024-05 0 $0 85,000 $5,794,606 8,000 $78,545
2024-04 0 $0 160,000 $10,656,765 8,000 $67,470
2024-03 0 $0 961,500 $71,899,532 42,000 $669,380
2023-12 0 $0 232,196 $17,512,622 113,046 $1,392,461
2023-11 0 $0 12,150 $724,467 3,000 $3,240
2023-10 0 $0 122,695 $6,377,954 30,995 $138,025
2023-09 0 $0 5,000 $234,890 5,000 $17,020
2023-08 0 $0 3,000 $149,640 3,000 $3,240

Table 3. Detailed insider trading at Nuvalent, Inc. (NUVL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-30 Balcom Alexandra (Chief Financial Officer) Sale 20,000 85.06 1,701,200
2025-09-30 Balcom Alexandra (Chief Financial Officer) Option Ex 20,000 6.89 137,800
2025-09-29 Noci Darlene (Chief Development Officer) Sale 4,000 83.27 333,096
2025-09-29 Noci Darlene (Chief Development Officer) Option Ex 4,000 27.85 111,400
2025-09-29 Balcom Alexandra (Chief Financial Officer) Sale 7,588 85.01 645,055
2025-09-29 Balcom Alexandra (Chief Financial Officer) Option Ex 7,588 6.89 52,281
2025-09-15 Porter James Richard (President and CEO) Sale 54,000 79.28 4,281,120
2025-09-15 Porter James Richard (President and CEO) Option Ex 54,000 18.93 1,022,220
2025-09-10 Pelish Henry E. (Chief Scientific Officer) Sale 3,725 78.83 293,641
2025-09-10 Pelish Henry E. (Chief Scientific Officer) Option Ex 3,725 25.37 94,503
2025-08-29 Pelish Henry E. (Chief Scientific Officer) Option Ex 5,007 .97 4,881
2025-08-25 Noci Darlene (Chief Development Officer) Sale 4,000 74.84 299,360
2025-08-25 Noci Darlene (Chief Development Officer) Option Ex 4,000 27.85 111,400
2025-08-15 Porter James Richard (President and CEO) Sale 27,000 76.03 2,052,891
2025-08-15 Porter James Richard (President and CEO) Option Ex 27,000 18.93 511,110
2025-08-07 Pelish Henry E. (Chief Scientific Officer) Sale 5,500 74.85 411,674
2025-08-07 Pelish Henry E. (Chief Scientific Officer) Option Ex 5,500 25.37 139,535
2025-07-30 Noci Darlene (Chief Development Officer) Sale 4,000 80.36 321,440
2025-07-30 Noci Darlene (Chief Development Officer) Option Ex 4,000 27.85 111,400
2025-07-16 Balcom Alexandra (Chief Financial Officer) Sale 44,100 85.10 3,752,910
2025-07-16 Balcom Alexandra (Chief Financial Officer) Option Ex 44,100 18.93 834,813
2025-07-15 Porter James Richard (President and CEO) Sale 81,000 83.11 6,731,505
2025-07-15 Porter James Richard (President and CEO) Option Ex 81,000 18.93 1,533,330
2025-07-15 Balcom Alexandra (Chief Financial Officer) Sale 15,900 84.23 1,339,302
2025-07-15 Balcom Alexandra (Chief Financial Officer) Option Ex 15,900 18.93 300,987
2025-07-10 Pelish Henry E. (Chief Scientific Officer) Sale 5,500 80.43 442,365
2025-07-10 Pelish Henry E. (Chief Scientific Officer) Option Ex 5,500 25.37 139,535
2025-07-09 Pelish Henry E. (Chief Scientific Officer) Sale 2,145 81.49 174,796
2025-06-27 Pelish Henry E. (Chief Scientific Officer) Sale 2,170 79.92 173,426
2025-06-27 Pelish Henry E. (Chief Scientific Officer) Option Ex 2,170 28.59 62,040
2025-06-27 Balcom Alexandra (Chief Financial Officer) Sale 20,000 80.02 1,600,400
2025-06-27 Balcom Alexandra (Chief Financial Officer) Option Ex 20,000 18.93 378,600
2025-06-26 Noci Darlene (Chief Development Officer) Sale 4,000 78.41 313,640
2025-06-26 Noci Darlene (Chief Development Officer) Option Ex 4,000 27.85 111,400
2025-06-25 Pelish Henry E. (Chief Scientific Officer) Sale 8,630 79.87 689,278
2025-06-25 Pelish Henry E. (Chief Scientific Officer) Option Ex 8,630 28.59 246,731
2025-06-16 Porter James Richard (President and CEO) Sale 27,000 77.38 2,089,259
2025-06-16 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-06-06 Pelish Henry E. (Chief Scientific Officer) Sale 200 79.82 15,963
2025-06-06 Pelish Henry E. (Chief Scientific Officer) Option Ex 200 28.59 5,718
2025-05-29 Noci Darlene (Chief Development Officer) Sale 4,000 71.46 285,840
2025-05-29 Noci Darlene (Chief Development Officer) Option Ex 4,000 21.12 84,500
2025-05-15 Porter James Richard (President and CEO) Sale 27,000 70.01 1,890,351
2025-05-15 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-04-29 Noci Darlene (Chief Development Officer) Sale 4,000 74.56 298,240
2025-04-29 Noci Darlene (Chief Development Officer) Option Ex 4,000 14.40 57,600
2025-04-15 Porter James Richard (President and CEO) Sale 27,000 69.53 1,877,445
2025-04-15 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-03-27 Noci Darlene (Chief Development Officer) Sale 4,000 73.37 293,480
2025-03-27 Noci Darlene (Chief Development Officer) Option Ex 4,000 16.66 66,660
2025-03-17 Porter James Richard (President and CEO) Sale 27,000 76.06 2,053,620
2025-03-17 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-03-07 Noci Darlene (Chief Development Officer) Sale 4,000 72.14 288,540
2025-03-07 Noci Darlene (Chief Development Officer) Option Ex 4,000 1.08 4,320
2025-03-06 Noci Darlene (Chief Development Officer) Sale 30,000 71.72 2,151,690
2025-03-06 Noci Darlene (Chief Development Officer) Option Ex 30,000 3.98 119,550
2025-02-24 Shair Matthew Sale 2,000 78.38 156,754
2025-02-18 Porter James Richard (President and CEO) Sale 27,000 78.72 2,125,575
2025-02-18 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-01-31 Pelish Henry E. (Chief Scientific Officer) Option Ex 3,120 .87 2,714
2025-01-27 Shair Matthew Sale 2,000 83.51 167,016
2025-01-15 Porter James Richard (President and CEO) Sale 27,000 76.09 2,054,565
2025-01-15 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2025-01-06 Pelish Henry E. (Chief Scientific Officer) Sale 2,483 79.38 197,107
2025-01-06 Miller Deborah Ann (Chief Legal Officer) Sale 2,964 79.38 235,291
2025-01-06 Porter James Richard (President and CEO) Sale 17,301 79.38 1,373,405
2025-01-06 Noci Darlene (Chief Development Officer) Sale 4,016 79.38 318,802
2025-01-06 Balcom Alexandra (Chief Financial Officer) Sale 4,016 79.38 318,802
2025-01-06 Turner Christopher Durant (Chief Medical Officer) Sale 4,016 79.38 318,802
2024-12-19 Porter James Richard (President and CEO) Option Ex 22,000 .65 14,300
2024-12-17 Balcom Alexandra (Chief Financial Officer) Option Ex 13,700 3.98 54,594
2024-12-16 Pelish Henry E. (Chief Scientific Officer) Option Ex 10,414 .76 7,914
2024-12-16 Porter James Richard (President and CEO) Sale 27,000 86.71 2,341,170
2024-12-16 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2024-12-11 Hack Andrew A. F. Sale 1,250,000 88.00 110,000,000
2024-11-29 Balcom Alexandra (Chief Financial Officer) Sale 10,000 95.97 959,700
2024-11-29 Balcom Alexandra (Chief Financial Officer) Option Ex 10,000 27.85 278,500
2024-11-25 Shair Matthew Sale 2,000 96.60 193,200
2024-11-15 Porter James Richard (President and CEO) Sale 27,000 88.47 2,388,690
2024-11-15 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2024-11-01 Noci Darlene (Chief Development Officer) Sale 5,000 88.94 444,685
2024-11-01 Noci Darlene (Chief Development Officer) Option Ex 5,000 14.40 72,000
2024-10-31 Balcom Alexandra (Chief Financial Officer) Sale 10,000 89.67 896,680
2024-10-31 Balcom Alexandra (Chief Financial Officer) Option Ex 10,000 27.85 278,500
2024-10-28 Shair Matthew Sale 2,000 92.23 184,460
2024-10-22 Deerfield Private Design Fund Iv, L.p. Sale 2,000,000 97.75 195,500,000
2024-10-15 Porter James Richard (President and CEO) Sale 27,000 102.64 2,771,145
2024-10-15 Porter James Richard (President and CEO) Option Ex 27,000 27.85 751,950
2024-09-30 Balcom Alexandra (Chief Financial Officer) Sale 10,000 100.50 1,004,980
2024-09-30 Balcom Alexandra (Chief Financial Officer) Option Ex 10,000 27.85 278,500
2024-09-23 Shair Matthew Sale 2,000 104.43 208,860
2024-09-16 Pelish Henry E. (Chief Scientific Officer) Sale 32,795 98.25 3,222,272
2024-09-16 Miller Deborah Ann (Chief Legal Officer) Sale 8,000 97.46 779,688
2024-09-16 Miller Deborah Ann (Chief Legal Officer) Option Ex 8,000 18.93 151,440
2024-09-09 Miller Deborah Ann (Chief Legal Officer) Sale 3,000 87.88 263,634
2024-09-09 Miller Deborah Ann (Chief Legal Officer) Option Ex 3,000 6.89 20,670
2024-09-03 Noci Darlene (Chief Development Officer) Sale 5,000 84.72 423,585
2024-09-03 Noci Darlene (Chief Development Officer) Option Ex 5,000 18.93 94,650
2024-08-30 Balcom Alexandra (Chief Financial Officer) Sale 10,000 84.79 847,930
2024-08-30 Balcom Alexandra (Chief Financial Officer) Option Ex 10,000 27.85 278,500
2024-08-26 Shair Matthew Sale 2,000 84.71 169,420
2024-08-23 Pelish Henry E. (Chief Scientific Officer) Sale 10,500 85.08 893,340
2024-08-23 Conley Emily Sale 3,334 85.02 283,456
2024-08-23 Conley Emily Option Ex 3,334 13.79 45,975
2024-08-23 Miller Deborah Ann (Chief Legal Officer) Sale 11,000 85.04 935,440
2024-08-23 Miller Deborah Ann (Chief Legal Officer) Option Ex 11,000 23.39 257,290
2024-08-08 Miller Deborah Ann (Chief Legal Officer) Sale 3,000 68.01 204,042
2024-08-08 Miller Deborah Ann (Chief Legal Officer) Option Ex 3,000 6.89 20,670
2024-07-29 Shair Matthew Sale 2,000 80.33 160,660
2024-07-15 Conley Emily Sale 5,000 80.76 403,815
2024-07-15 Conley Emily Option Ex 5,000 13.79 68,950
2024-07-12 Miller Deborah Ann (Chief Legal Officer) Sale 6,000 80.16 480,960
2024-07-12 Miller Deborah Ann (Chief Legal Officer) Option Ex 6,000 27.85 167,100
2024-07-08 Miller Deborah Ann (Chief Legal Officer) Sale 3,000 73.07 219,200
2024-07-08 Miller Deborah Ann (Chief Legal Officer) Option Ex 3,000 6.89 20,670
2024-07-01 Noci Darlene (Chief Development Officer) Sale 5,000 75.83 379,125
2024-07-01 Noci Darlene (Chief Development Officer) Option Ex 5,000 18.93 94,650
2024-06-28 Balcom Alexandra (Chief Financial Officer) Sale 10,000 76.02 760,230
2024-06-28 Balcom Alexandra (Chief Financial Officer) Option Ex 10,000 27.85 278,500
2024-06-24 Shair Matthew Sale 2,000 80.32 160,634
2024-06-14 Conley Emily Sale 5,000 77.92 389,575
2024-06-14 Conley Emily Option Ex 5,000 13.79 68,950
2024-06-06 Miller Deborah Ann (Chief Legal Officer) Sale 8,000 78.11 624,864
2024-06-06 Miller Deborah Ann (Chief Legal Officer) Option Ex 8,000 12.91 103,280
2024-05-28 Shair Matthew Sale 2,000 67.77 135,534
2024-05-15 Conley Emily Sale 5,000 69.09 345,450
2024-05-15 Conley Emily Option Ex 5,000 11.57 57,875
2024-05-13 Shair Matthew Sale 37,500 66.13 2,479,987
2024-05-06 Shair Matthew Sale 37,500 69.77 2,616,375
2024-05-02 Miller Deborah Ann (Chief Legal Officer) Sale 3,000 72.42 217,260
2024-05-02 Miller Deborah Ann (Chief Legal Officer) Option Ex 3,000 6.89 20,670
2024-04-29 Shair Matthew Sale 39,500 67.80 2,677,981
2024-04-22 Shair Matthew Sale 37,500 63.66 2,387,250
2024-04-15 Conley Emily Sale 5,000 66.09 330,450
2024-04-15 Conley Emily Option Ex 5,000 9.36 46,800
2024-04-15 Shair Matthew Sale 37,500 65.72 2,464,500
2024-04-08 Shair Matthew Sale 37,500 68.72 2,577,000
2024-04-04 Miller Deborah Ann (Chief Legal Officer) Sale 3,000 73.19 219,584
2024-04-04 Miller Deborah Ann (Chief Legal Officer) Option Ex 3,000 6.89 20,670
2024-03-28 Miller Deborah Ann (Chief Legal Officer) Sale 22,000 75.13 1,652,860
2024-03-28 Miller Deborah Ann (Chief Legal Officer) Option Ex 22,000 23.39 514,580
2024-03-27 Hack Andrew A. F. Sale 880,000 74.59 65,643,600
2024-03-25 Shair Matthew Sale 39,500 77.06 3,043,672
2024-03-22 Noci Darlene (Chief Development Officer) Sale 20,000 77.97 1,559,400
2024-03-22 Noci Darlene (Chief Development Officer) Option Ex 20,000 7.74 154,800
2023-12-28 Shair Matthew (Director) Sale 48,548 75.67 3,673,627
2023-12-27 Shair Matthew (Director) Sale 1,000 75.17 75,170
2023-12-26 Shair Matthew (Director) Sale 69,602 74.67 5,197,529
2023-12-19 Miller Deborah Ann (Chief Legal Officer) Sale 5,000 75.00 375,000
2023-12-19 Miller Deborah Ann (Chief Legal Officer) Option Ex 5,000 18.93 94,650
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of NUVL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvalent, Inc. (symbol NUVL, CIK number 1861560) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.